Management of HBV Infection During Immunosuppressive Treatment
2009

Management of HBV Infection During Immunosuppressive Treatment

publication Evidence: moderate

Author Information

Author(s): Marzano Alfredo

Primary Institution: San Giovanni Battista Hospital, Turin, Italy

Conclusion

A rational approach to managing hepatitis B virus (HBV) in immunocompromised patients includes screening, antiviral treatment for active carriers, and prophylaxis for inactive carriers.

Supporting Evidence

  • Two billion people are overt carriers of HBV worldwide, with 360 million suffering from chronic infection.
  • Over 520,000 die each year from HBV-related complications.
  • Immunosuppression can lead to HBV reactivation, which complicates treatment and survival.

Takeaway

This study talks about how to take care of people with hepatitis B who are getting treatments that weaken their immune system, like chemotherapy. It suggests checking for the virus and using medicine to prevent problems.

Limitations

The literature on hepatitis B in immunocompromised patients is heterogeneous and mainly refers to the pre-antivirals era, which complicates interpretation.

Digital Object Identifier (DOI)

10.4084/MJHID.2009.025

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication